YARROW BIOSCIENCE, INC. Cash and Cash Equivalents
YARROW BIOSCIENCE, INC. (YARW) had Cash and Cash Equivalents of $22.93 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-13
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $22.93M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $24.63M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $24.03M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $22.05M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $22.93M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $24.63M S-4/A · filed 2026-06-03 | |
| 2025-12-31 | $24.03M 10-Q · filed 2026-08-13 | |
| 2025-06-30 | $22.05M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $28.21M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $19.93M S-4/A · filed 2026-06-03 | |
| 2024-09-30 | $16.27M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $29.61M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | $19.07M 10-Q · filed 2025-05-08 | |
| 2023-12-31 | $30.62M 10-K · filed 2025-03-06 | |
| 2023-09-30 | $15.45M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $20.63M 10-Q · filed 2024-08-14 | |
| 2023-03-31 | $30.21M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $30.91M 10-K · filed 2024-03-01 | |
| 2022-09-30 | $35.51M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $42.81M 10-Q · filed 2023-08-14 | |
| 2022-03-31 | $50.49M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $42.25M 10-K · filed 2023-03-14 | |
| 2021-09-30 | $52.31M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $103.41M 10-Q · filed 2022-08-12 | |
| 2021-03-31 | $118.52M 10-Q · filed 2022-05-12 | |
| 2020-12-31 | $57.56M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $72.96M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $96.51M 10-Q · filed 2021-08-12 | |
| 2020-03-31 | $57.60M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $43.76M 10-K · filed 2021-03-04 | $30.78M 10-K · filed 2020-03-03 |
| 2019-09-30 | $40.53M 10-Q · filed 2020-11-05 | $34.24M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $39.09M 10-Q · filed 2020-08-06 | $65.06M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $18.99M 10-Q · filed 2020-05-11 | $61.96M 10-Q · filed 2019-05-02 |
| 2018-12-31 | $27.87M 10-K · filed 2021-03-04 | $49.51M 10-K · filed 2019-02-28 |
| 2018-09-30 | $70.20M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $73.58M 10-Q · filed 2019-08-01 | |
| 2018-03-31 | $78.53M 10-Q · filed 2019-05-02 | |
| 2017-12-31 | $10.21M 10-Q · filed 2019-08-01 | |
| 2017-09-30 | $14.96M 10-Q · filed 2018-11-07 | |
| 2017-06-30 | $13.42M 10-Q · filed 2018-08-01 | |
| 2017-03-31 | $6.03M 10-Q · filed 2018-05-09 | |
| 2016-12-31 | $4.03M 10-K · filed 2019-02-28 | |
| 2015-12-31 | $43.81M 10-K · filed 2019-02-28 | |
| 2014-12-31 | $273.00K 10-K · filed 2018-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |